| ADR Ontology |
| ADR Term |
Haemolytic anaemia |
| ADR ID |
BADD_A01933 |
| ADR Hierarchy |
|
| Description |
A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). | Acquired anemia due to destruction of red blood cells by physical trauma such as FIBRIN strands in the blood vessels, artificial heart valve, AORTIC COARCTATION. I can also be associated with hematologic diseases such as DISSEMINATED INTRAVASCULAR COAGULATION; HEMOLYTIC-UREMIC SYNDROME; and THROMBOTIC THROMBOCYTOPENIC PURPURA. [MeSH] |
| MedDRA Code |
10018916 |
| MeSH ID |
D000743
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Acquired haemolytic anaemia | Acquired haemolytic anaemia, unspecified | Acquired haemolytic anaemias | Acquired hemolytic anemia, unspecified | Acquired hemolytic anemias | Anaemia haemolytic | Anaemia primaquine sensitivity | Anemia hemolytic (NOS) | Anemia hemolytic occult | Anemia primaquine sensitivity type | Haemolytic anaemia | Haemolytic anaemia acquired | Haemolytic anaemia drug-induced | Haemolytic anaemia NOS | Hemolytic anemia | Hemolytic anemia (NOS) | Hemolytic anemia with antidrug antibody | Non-autoimmune haemolytic anaemia | Non-autoimmune haemolytic anaemias | Non-autoimmune hemolytic anemia, unspecified | Non-autoimmune hemolytic anemias | Other non-autoimmune hemolytic anemias | Primaquine sensitivity anaemia | Primaquine sensitivity anemia | Acquired hemolytic anemia | Anemia hemolytic | Hemolytic anemia acquired | Hemolytic anemia drug-induced | Non-autoimmune hemolytic anemia | Anaemia haemolytic occult | Haemolytic anaemia with antidrug antibody | Non-autoimmune haemolytic anaemia, unspecified | Anaemia primaquine sensitivity type | Acute hemolytic anemia | Acute haemolytic anaemia | Anemia, Hemolytic | Hemolytic Anemia | Microangiopathic Hemolytic Anemia | Anemia, Hemolytic, Acquired | Hemolytic Anemia, Acquired | Acquired Hemolytic Anemia | Anemia, Acquired Hemolytic | Anemia, Microangiopathic | Microangiopathic Anemia |
|
|
| Drugs Leading to the ADR |
|
|
